Rogell G D
Retina. 1983 Fall-Winter;3(4):308-11. doi: 10.1097/00006982-198300340-00015.
Since 1977, the author has treated proliferative diabetic retinopathy (PDR) under a protocol using DRS-style panretinal photocoagulation (PRP), with supplemental PRP, panretinal cryotherapy, and vitrectomy as needed. A total of 55 eyes (33 patients) were started on this protocol between 1/1/77 and 4/30/82. Follow-up averages 33 months (range: 12-80 months). Forty-nine eyes (89%) required PRP only; two eyes received panretinal cryotherapy, and four had vitrectomies. Visual acuity was maintained or improved in 44 eyes (80%); 48 eyes (87%) retained visual acuity of 20/100 or better. The major cause of visual loss was diabetic maculopathy.
自1977年以来，作者按照一项使用糖尿病视网膜病变研究（DRS）式全视网膜光凝（PRP）的方案治疗增殖性糖尿病视网膜病变（PDR），并根据需要辅以补充性PRP、全视网膜冷冻疗法和玻璃体切除术。在1977年1月1日至1982年4月30日期间，共有55只眼（33例患者）开始采用该方案治疗。随访平均33个月（范围：12 - 80个月）。49只眼（89%）仅需PRP治疗；2只眼接受了全视网膜冷冻疗法，4只眼进行了玻璃体切除术。44只眼（80%）的视力得以维持或提高；48只眼（87%）的视力保持在20/100或更好。视力丧失的主要原因是糖尿病性黄斑病变。
